All Stories

  1. Identification of Butyrylcholinesterase and Monoamine Oxidase B Targeted Ligands and their Putative Application in Alzheimer’s Treatment: A Computational Strategy
  2. The role of mitochondrial defects and oxidative stress in Alzheimer’s disease
  3. Effect of Diterpenes on Hepatic System
  4. An Insight into the Therapeutic Potential of Major Coffee Components
  5. The use of Azoles Containing Natural Products in Cancer Prevention and Treatment: An Overview
  6. Exploration of Various Proteins for the Treatment of Alzheimer's Disease
  7. Elucidating Treatment of Alzheimer's Disease via Different Receptors
  8. Potential Linkage Between Cerebrovascular Diseases and Metabolic Syndrome
  9. Cardiovascular disease management through restrained inflammatory responses
  10. Current Updates on Therapeutic Advances in the Management of Cardiovascular Diseases
  11. An Overview on Global Trends in Nanotechnological Approaches for Alzheimer Therapy
  12. DNA Glycation from 3-Deoxyglucosone Leads to the Formation of AGEs: Potential Role in Cancer Auto-antibodies
  13. A Synopsis of Nano-Technological Approaches Toward Anti-Epilepsy Therapy: Present and Future Research Implications
  14. Oxidative Stress Mediated Cytotoxicity of Glycated Albumin: Comparative Analysis of Glycation by Glucose Metabolites
  15. Integrating Qualitative and Quantitative Tools for the Detection and Identification of Lectins in Major Human Diseases
  16. Effect of trifluoroethanol on α-crystallin: folding, aggregation, amyloid, and cytotoxicity analysis
  17. Neopterin: An immune biomarker of coronary artery disease and its association with other CAD markers
  18. Quercetin as a finer substitute to aminoguanidine in the inhibition of glycation products
  19. Physico-chemical stress induced amyloid formation in insulin: Amyloid characterization, cytotoxicity analysis against human neuroblastoma cell lines and its prevention using black seeds (Nigella sativa)
  20. Reno-protective effect of garlic extract against immobilization stress induced changes in rats
  21. Certain Phase I and II Enzymes as Toxicity Biomarker: An Overview
  22. Correlation of Toll-Like Receptor 4, Interleukin-18, Transaminases, and Uric Acid in Patients With Chronic Periodontitis and Healthy Adults
  23. Reduction of post-prandial hyperglycemia by mulberry tea in type-2 diabetes patients
  24. Differential effects of anti-cancer and anti-hepatitis drugs on liver cystatin
  25. Studies on the role of goat heart galectin-1 as a tool for detecting post-malignant changes in glycosylation pattern
  26. An overview on the correlation of neurological disorders with cardiovascular disease
  27. Studies on the role of goat heart galectin-1 as an erythrocyte membrane perturbing agent
  28. Effects of extremely low frequency electromagnetic field (ELF-EMF) on catalase, cytochrome P450 and nitric oxide synthase in erythro-leukemic cells
  29. Synopsis on the Linkage of Alzheimer's and Parkinson's Disease with Chronic Diseases
  30. Pro-oxidant DNA Breakage Induced by the Interaction of L-DOPA with Cu(II): A Putative Mechanism of Neurotoxicity
  31. Altered Galectin Glycosylation: Potential Factor for the Diagnostics and Therapeutics of Various Cardiovascular and Neurological Disorders
  32. Protein Misfolding and Aggregation in Alzheimer’s Disease and Type 2 Diabetes Mellitus
  33. Specific Cholinesterase Inhibitors: A Potential Tool to Assist in Management of Alzheimer Disease
  34. Immunogenicity of DNA-advanced glycation end product fashioned through glyoxal and arginine in the presence of Fe3+: Its potential role in prompt recognition of diabetes mellitus auto-antibodies
  35. Comparative Study of Non-High Density Lipoproteins Cholesterol Level and Lipid Profile in Pre-Diabetic and Diabetic Patients
  36. How Do Periodontal Infections Affect the Onset and Progression of Alzheimer’s Disease?
  37. Prediction of Comparative Inhibition Efficiency for a Novel Natural Ligand, Galangin Against Human Brain Acetylcholinesterase, Butyrylcholinesterase and 5-Lipoxygenase: A Neuroinformatics Study
  38. Current Acetylcholinesterase-Inhibitors: A Neuroinformatics Perspective
  39. Linking Alzheimer’s Disease and Type 2 Diabetes Mellitus via Aberrant Insulin Signaling and Inflammation
  40. Alzheimer’s and Type 2 Diabetes Treatment via Common Enzyme Targeting
  41. Gene–environment interactions in heavy metal and pesticide carcinogenesis
  42. Protective Effect of Solanum nigrum Leaves Extract on Immobilization Stress Induced Changes in Rat’s Brain
  43. Specific Cholinesterase Inhibitors: A Potential Tool to Assist in Management of Alzheimer Disease
  44. Ribosylation of bovine serum albumin induces ROS accumulation and cell death in cancer line (MCF-7)
  45. MicroRNA: Novel Modulators of the Cholinergic Anti-Inflammatory Pathway
  46. Use of Pseudomonas spp. for the bioremediation of environmental pollutants: a review
  47. Benzo(a)pyrene induced structural and functional modifications in lung cystatin
  48. Link between Cancer and Alzheimer Disease via Oxidative Stress Induced by Nitric Oxide-Dependent Mitochondrial DNA Overproliferation and Deletion
  49. A Region-specific Treatment Strategy To Address The Problem Of Drug Resistance By NDM-1-producing Pathogens
  50. Cancer Chemoprevention by Polyphenols and Their Potential Application as Nanomedicine
  51. Cytochrome P450 system as potential biomarkers of certain toxicants: comparison between plant and animal models
  52. Toxicological effects of major environmental pollutants: an overview
  53. Targeting Parkinson’s - Tyrosine Hydroxylase and Oxidative Stress as Points of Interventions
  54. A Synopsis on the Role of Tyrosine Hydroxylase in Parkinson’s Disease
  55. Genotoxicity of trichloroethylene in the natural milieu
  56. Interaction of Human Brain Acetylcholinesterase with Cyclophosphamide: A Molecular Modeling and Docking Study
  57. Oxidative stress-mediated genotoxicity of wastewaters collected from two different stations in northern India
  58. Genotoxicity Testing and Biomarker Studies on Surface Waters: An Overview of the Techniques and Their Efficacies
  59. Detoxification Potential of Pseudomonas fluorescens SM1 Strain for Remediation of Major Toxicants in Indian Water Bodies
  60. Some enzymatic/nonenzymatic antioxidants as potential stress biomarkers of trichloroethylene, heavy metal mixture, and ethyl alcohol in rat tissues
  61. Mutagenicity of industrial wastewaters collected from two different stations in northern India
  62. Suitability of Immobilized Pseudomonas fluorescens SM1 Strain for Remediation of Phenols, Heavy Metals, and Pesticides from Water
  63. Components of antioxidative system inAllium cepaas the toxicity monitor of trichloroethylene (TCE)
  64. Short-term in vitro and in vivo genotoxicity testing systems for some water bodies of Northern India
  65. Validation of plant based bioassays for the toxicity testing of Indian waters
  66. Cytochrome P450 system as a toxicity biomarker of industrial wastewater in rat tissues
  67. Effect of wastewater intake on antioxidant and marker enzymes of tissue damage in rat tissues: Implications for the use of biochemical markers
  68. Toxicity, Biomarkers, Genotoxicity, and Carcinogenicity of Trichloroethylene and Its Metabolites: A Review